CTOs on the Move

Medical Practice Innovations

www.mpimed.com

 
Medical Practice Innovations is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mpimed.com
  • 260 Ainslie St
    Brooklyn, NY USA 11211
  • Phone: 718.388.1600

Executives

Name Title Contact Details

Similar Companies

Quantum Intech (QI)

Quantum Intech (QI) is a Boulder Creek, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ortonville Area Health Services

Ortonville Area Health Services is a healthcare system that includes Ortonville Hospital, Northridge Residence (nursing home), Northside Medical Clinic, Clinton Clinic, and OAHS Home Health Agency. They offer a broad scope of services to keep you and y...

Anthelio Healthcare

Anthelio Healthcare Solutions Inc. is much more than a healthcare IT company. We are a single source provider of world-class technology solutions for the healthcare industry with a 15-year history of excellence. Our innovative services and products make it easier for our customers to do what they do best – deliver outstanding patient care. Our company was built on the foundation that healthcare is our only business, uniquely positioning us as one of the very few companies who focus solely on the needs of our healthcare customers and their patients. We take great pride in maintaining the highest levels of client satisfaction for the hundreds of U.S. hospitals and healthcare providers we serve. We strive to provide a unique customer experience by proactively anticipating our customers' needs and pain points and by delivering fast, flexible and bold solutions. In an ever-evolving healthcare industry, we are at the forefront of delivering cutting-edge, scalable technologies and solutions that respond to the market's needs while maintaining sustainable value to our customers.

Ayr Wellness

Must be 21+ We aim higher for the wellness of our customers, through the power of cannabis.

Wave Life Sciences

WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.